Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2023

21-01-2023 | Obesity | Fellows and Young GIs

Broadening Horizons: Why Gastroenterologists Should Consider a Career in Obesity Medicine

Authors: Albert Do, Jin Xu

Published in: Digestive Diseases and Sciences | Issue 3/2023

Login to get access

Excerpt

For starting gastroenterology (GI) fellows, or for gastroenterologists in practice, specializing in obesity medicine may not be the first option that crosses your mind. And yet, given its increasing importance and relevance to all facets of medicine, pursuing a career in obesity medicine to some represents a satisfying and stimulating niche in gastroenterology. In this paper, we will make the case for choosing a career in obesity medicine for GI fellows and practitioners. …
Literature
1.
go back to reference Collaborators GO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.CrossRef Collaborators GO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.CrossRef
2.
go back to reference Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018. NCHS Health e-stats. 2020:1–7. Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018. NCHS Health e-stats. 2020:1–7.
4.
go back to reference Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology. 2017;152:1656–1670.CrossRefPubMed Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology. 2017;152:1656–1670.CrossRefPubMed
5.
go back to reference Younossi Z, Stepanova M, Ong JP et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17:748–755.CrossRefPubMed Younossi Z, Stepanova M, Ong JP et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17:748–755.CrossRefPubMed
6.
go back to reference Newsome PN, Buchholtz K, Cusi K et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384:1113–1124.CrossRefPubMed Newsome PN, Buchholtz K, Cusi K et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384:1113–1124.CrossRefPubMed
11.
go back to reference Wadden TA, Bray GA. Handbook of Obesity Treatment. New York: Guilford Publications; 2018. Wadden TA, Bray GA. Handbook of Obesity Treatment. New York: Guilford Publications; 2018.
Metadata
Title
Broadening Horizons: Why Gastroenterologists Should Consider a Career in Obesity Medicine
Authors
Albert Do
Jin Xu
Publication date
21-01-2023
Publisher
Springer US
Keywords
Obesity
Obesity
Published in
Digestive Diseases and Sciences / Issue 3/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-07827-2

Other articles of this Issue 3/2023

Digestive Diseases and Sciences 3/2023 Go to the issue

REVIEWER ACKNOWLEDGMENT

Acknowledgment of 2022 Reviewers

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare